Your browser doesn't support javascript.
loading
Biomarkers in chronic graft-versus-host disease: quo vadis?
Wolff, D; Greinix, H; Lee, S J; Gooley, T; Paczesny, S; Pavletic, S; Hakim, F; Malard, F; Jagasia, M; Lawitschka, A; Hansen, J A; Pulanic, D; Holler, E; Dickinson, A; Weissinger, E; Edinger, M; Sarantopoulos, S; Schultz, K R.
Afiliação
  • Wolff D; Department of Internal Medicine III, University Hospital of Regensburg, Regensburg, Germany. daniel.wolff@ukr.de.
  • Greinix H; Division of Haematology, Department of Internal Medicine, Medical University of Graz, Graz, Austria.
  • Lee SJ; Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA.
  • Gooley T; Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA.
  • Paczesny S; Department of Pediatrics, Indiana University School of Medicine, Indianapolis, IN, USA.
  • Pavletic S; Experimental Transplantation and Immunology Branch, Center of Cancer Research, National Cancer Institute, Bethesda, MD, USA.
  • Hakim F; Experimental Transplantation and Immunology Branch, Center of Cancer Research, National Cancer Institute, Bethesda, MD, USA.
  • Malard F; Hematology Department, Hôpital Saint-Antoine; Université Pierre & Marie Curie; and INSERM, Centre de Recherche Saint-Antoine, UMRS U938, Paris, France.
  • Jagasia M; Department of Hematology and Oncology, Vanderbilt University Medical Center, Nashville, TN, USA.
  • Lawitschka A; St. Anna Children's Hospital, Medical University Vienna, Vienna, Austria.
  • Hansen JA; Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA.
  • Pulanic D; Division of Hematology, Department of Internal Medicine, University Hospital Center Zagreb, and Medical School University of Zagreb, Zagreb, Croatia.
  • Holler E; Faculty of Medicine Osijek, J. J. Strossmayer University of Osijek, Osijek, Croatia.
  • Dickinson A; Department of Internal Medicine III, University Hospital of Regensburg, Regensburg, Germany.
  • Weissinger E; Institute of Cellular Medicine, Newcastle University, Newcastle, UK.
  • Edinger M; Department of Hematology, Hemostasis, Oncology and Stem Cell Transplantation, Hannover Medical School, Hannover, Germany.
  • Sarantopoulos S; Department of Internal Medicine III, University Hospital of Regensburg, Regensburg, Germany.
  • Schultz KR; Department of Medicine, Division of Hematological Malignancies & Cellular Therapy, Duke Cancer Institute, Duke University Medical Center, Durham, NC, USA.
Bone Marrow Transplant ; 53(7): 832-837, 2018 07.
Article em En | MEDLINE | ID: mdl-29367715

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Biomarcadores / Doença Enxerto-Hospedeiro Tipo de estudo: Prognostic_studies Limite: Female / Humans / Male Idioma: En Ano de publicação: 2018 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Biomarcadores / Doença Enxerto-Hospedeiro Tipo de estudo: Prognostic_studies Limite: Female / Humans / Male Idioma: En Ano de publicação: 2018 Tipo de documento: Article